1
Bosma, Angela L., de Wijs, Linde E.M., Hof, Michel H., van Nieuwenhuizen, Beau R., Gerbens, Louise A.A., Middelkamp-Hup, Maritza A., Hijnen, Dirk Jan, Spuls, Phyllis I.
Veröffentlicht in: Bosma , A L , de Wijs , L E M , Hof , M H , van Nieuwenhuizen , B R , Gerbens , L A A , Middelkamp-Hup , M A , Hijnen , D J & Spuls , P I 2021 , ' Response to : “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry’” ' , Journal of the American Academy of Dermatology , vol. 85 , no. 3 , pp. e173-e174 . https://doi.org/10.1016/j.jaad.2021.02.072;
2021
Veröffentlicht in: Bosma , A L , de Wijs , L E M , Hof , M H , van Nieuwenhuizen , B R , Gerbens , L A A , Middelkamp-Hup , M A , Hijnen , D J & Spuls , P I 2021 , ' Response to : “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry’” ' , Journal of the American Academy of Dermatology , vol. 85 , no. 3 , pp. e173-e174 . https://doi.org/10.1016/j.jaad.2021.02.072;
2021
2
3